SF
Seamus Fernandez Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
32
Avg Return
Past Year
Past Year
40%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
88.2%
Neutral
11.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $34 |
135%
upside
| 3 | +39% |
0
%
| 16 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $35 |
43%
upside
| 2 | +26% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $143 |
61%
upside
| 3 | +2.1% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $72 |
20%
upside
| 2 | +8.2% |
0
%
| 6 Feb ‘26 2 months ago |
|
|
|
Buy
Initiated
| $27 |
317%
upside
| 1 | -17% |
0
%
| 3 Feb ‘26 2 months ago |
|
|
|
Buy
Reiterated
| $116 |
86%
upside
| 1 | +2.3% |
0
%
| 2 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $1,161 |
25%
upside
| 7 | +5.7% |
0
%
| 20 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $140 |
176%
upside
| 2 | +204% |
0
%
| 20 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $88 |
161%
upside
| 4 | +69% |
0
%
| 16 Jan ‘26 3 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 9 Dec ‘25 4 months ago |
|
|
|
Buy
Maintained
| $11 |
94%
upside
| 1 | +48% |
0
%
| 18 Nov ‘25 5 months ago |
|
|
|
Neutral
Downgraded
| – | – | 5 | +92% |
0
%
| 18 Nov ‘25 5 months ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | – |
–
| 23 Oct ‘25 5 months ago |
|
|
|
Buy
Maintained
| $25 |
36%
upside
| 2 | +79% |
0
%
| 15 Sep ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $116 |
26%
upside
| 1 | +60% |
0
%
| 2 Jul ‘25 9 months ago |
|